Tag:
Cumberland Pharmaceuticals
Latest Headlines
Latest Headlines
Burnished at Vanderbilt, old drug program revived at Cumberland
An experimental drug that wound its way through a number of mid-stage cardiovascular studies at Bristol-Myers Squibb only to be donated to Vanderbilt University has now landed back in the hands of a
Cumberland pulls lots of particulate-plagued liver drug
Just as the year marches to its inevitable end, we have yet another particle-related recall to add to 2010's tally. Cumberland Pharmaceuticals is pulling six lots of its injectable liver drug,
Former Genentech CEO Levinson joins Amyris' board
> AVI BioPharma's board has appointed CFO J. David Boyle II as interim president and CEO. The appointment follows former CEO and director Leslie Hudson's resignation. The board plans to initiate a
Cumberland's injection meets study goal
Cumberland Pharmaceuticals--which pulled off an IPO over the summer--unveiled positive results from a study evaluating the safety and efficacy of Caldolor (ibuprofen) injection in treating fever in
Cumberland raises $85M, ending IPO drought
Nashville-based Cumberland Pharmaceuticals has broken a nearly two-year long drought of biopharma IPOs, raising $85 million in a public offering. Cumberland had expected to sell its shares for $19 to
